IBM’s Software-Led Rebound Faces a Defining Moment at Q2 Earnings

IBM shares face a pivotal Q2 earnings report on July 22. Can AI and software growth offset mainframe erosion? Bank of America raises target to $330, but technicals show mixed signals.

With second?quarter results due on 22 July 2026, IBM’s shares are entering a period of heightened scrutiny. After a strong run that has left the stock trading more than 8% higher over the past month, the market’s attention is fixed on a single question: can the acceleration in software and AI?related deals offset a steady erosion in the mainframe business? The answer will determine whether a valuation that has expanded to 22–23 times forward earnings is sustainable or due for a correction.

Bank of America has thrown its weight behind the bull case, lifting its price target on IBM to US$330 from US$315 while maintaining a buy rating. The firm expects the technology giant to post second?quarter revenue of US$18bn and adjusted earnings of US$3.03 per share. Much of the optimism hinges on the US$11bn acquisition of Confluent, which BofA believes is generating cost savings faster than anticipated. The integration is forecast to contribute roughly US$340m to quarterly sales and account for about 5% of software segment growth. On a constant?currency basis, BofA models automation software rising 11%, Red Hat climbing 10%, consulting adding 2%, and infrastructure declining 2%.

Yet the stock’s recent retreat shows that not everyone is convinced. After rallying on the analyst upgrade, IBM shares fell 2.14% in a single session as investors locked in profits, and the latest trade at €261.60 still leaves the security 10.67% below its 52?week high of €292.85. The consensus price target from the broader analyst community stands at €257.58 — marginally below the current level — suggesting that much of the good news is already priced in. A stretched price?to?earnings multiple leaves little room for disappointment.

Technically, the situation is mixed. The relative strength index sits at a comfortable 63.8, well short of overbought territory, and the stock trades 15.09% above its 50?day moving average, pointing to intact but not overheated momentum. At the same time, annualized 30?day volatility has climbed to 48.6%, reflecting a market that is bracing for a wide range of outcomes around the earnings release. The shares currently stand 10.38% above their 200?day average, a cushion that could quickly evaporate if the numbers underwhelm.

The bull path is straightforward: if Red Hat and automation maintain double?digit growth while management raises its full?year guidance on both revenue and free cash flow, the stock could march back toward its 52?week peak. BofA’s Wamsi Mohan believes an upward revision is likely, citing the faster?than?expected Confluent synergies. The bear case, however, revolves around the risk that infrastructure headwinds persist into the second half of 2026 and that cross?selling from the Confluent deal fails to materialise convincingly. In that scenario, the shares could slide to the 200?day moving average near €237, a level that would represent a roughly 9% decline from today’s price.

IBM has also refreshed its mainframe lineup with single?frame and rack versions of the z17 and LinuxONE?5 systems, incorporating a dedicated AI accelerator to appeal to modern data?centre buyers. While that supports the long?term hardware narrative, it does little to alter the near?term calculus. The 22 July report will reveal whether software growth is strong enough to carry the load — or whether the market’s current premium on IBM stock is built on hope rather than proof.